22 results
Keyword Avamys Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Avamys (updated)
fluticasone furoate, Rhinitis, Allergic, Seasonal, Rhinitis, Allergic, Perennial
Date of authorisation: 11/01/2008, Revision: 21, Authorised, Last updated: 02/03/2021Avamys Rhinitis, Allergic, Seasonal Rhinitis … part of the EPAR). What is Avamys Avamys is a nasal spray that contains … fluticasone furoate. What is Avamys used for Avamys is used to treat the symptoms … -
List item
Human medicine European public assessment report (EPAR): Alisade
fluticasone furoate, Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal
Date of authorisation: 06/10/2008, Revision: 4, Withdrawn, Last updated: 18/10/2011Alisade is no longer valid. Avamys (fluticasone furoate) is … authorisation granted to Avamys in January 2008 (‘informed … -
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 18, Authorised, Last updated: 13/05/2019 -
List item
Human medicine European public assessment report (EPAR): Revinty Ellipta
fluticasone furoate, vilanterol trifenatate, Asthma
Date of authorisation: 02/05/2014, Revision: 17, Authorised, Last updated: 21/05/2019 -
List item
Referral: Metformin and metformin-containing medicines
metformin, associated names: Xigduo, Vipdomet, Velmetia, Synjardy, Ristfor, Komboglyze, Jentadueto, Janumet, Icandra (previously Vildagliptin / metformin hydrochloride Novartis), Glubrava, Eucreas, Efficib, Ebymect, Competact, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/10/2016, EC decision date: 12/12/2016, Last updated: 21/12/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2014
European Medicines Agency, London, UK, from 06/01/2014 to 09/01/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 May 2014
European Medicines Agency, London, UK, from 05/05/2014 to 08/05/2014, Last updated: 13/08/2013 -
List item
Download medicine data
Last updated: 29/04/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 November-3 December 2015
European Medicines Agency, London, UK, from 30/11/2015 to 03/12/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 June 2016
European Medicines Agency, London, UK, from 06/06/2016 to 09/06/2016, Last updated: 13/03/2014 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 October 2007
CHMP, Last updated: 18/10/2007time of 202 days. • Avamys (fluticasone furoate), from … -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 16/02/2021 -
List item
Public data from Article 57 database (updated)
Last updated: 16/02/2021 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 July 2008
CHMP, Last updated: 25/07/2008days. Reference medicine is Avamys, from Glaxo Group Ltd … -
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 October 2017
European Medicines Agency, London, UK, from 09/10/2017 to 12/10/2017, Last updated: 06/01/2014 -
List item
PRAC: meeting archive 2014-2015
Last updated: 13/05/2016 -
List item
Quality assessors training
London, from 27/10/2009 to 28/10/2009, Last updated: 27/10/2009 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 December 2017
European Medicines Agency, London, UK, from 11/12/2017 to 14/12/2017, Last updated: 06/01/2014 -
List item
Annual reports and work programmes
Last updated: 15/06/2020 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013 -
List item
Press release: EMEA reports strong performance in regulatory and public-health activities in 2007; the outlook for 2008 is even higher application numbers and a focus on advanced-therapy medicines
Last updated: 10/03/2008 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020